CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 51 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.08 and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,495,904 | +4.5% | 694,885 | +0.0% | 0.00% | 0.0% |
| Q2 2023 | $4,301,197 | +117.9% | 694,862 | +35.2% | 0.00% | +50.0% |
| Q1 2023 | $1,973,516 | +23.8% | 514,116 | -0.1% | 0.00% | +100.0% |
| Q4 2022 | $1,594,726 | -23.1% | 514,428 | -0.3% | 0.00% | -50.0% |
| Q3 2022 | $2,073,000 | -17.8% | 515,746 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $2,521,000 | -45.7% | 517,577 | +0.1% | 0.00% | -33.3% |
| Q1 2022 | $4,639,000 | -20.3% | 517,235 | +0.0% | 0.00% | -25.0% |
| Q4 2021 | $5,823,000 | -5.8% | 517,123 | +39.7% | 0.00% | 0.0% |
| Q3 2021 | $6,184,000 | -25.1% | 370,292 | -0.3% | 0.00% | -33.3% |
| Q2 2021 | $8,251,000 | – | 371,504 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,937,615 | $19,006,369 | 42.74% |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $129,161,626 | 41.24% |
| Vida Ventures Advisors, LLC | 3,931,818 | $25,438,862 | 39.38% |
| TCG Crossover Management, LLC | 2,040,816 | $13,204,079 | 1.94% |
| Affinity Asset Advisors, LLC | 1,018,091 | $6,587,049 | 1.85% |
| BVF INC/IL | 9,103,054 | $58,896,759 | 1.59% |
| Sio Capital Management, LLC | 756,891 | $4,897,085 | 1.52% |
| ACUTA CAPITAL PARTNERS, LLC | 323,349 | $2,092,068 | 1.40% |
| EcoR1 Capital, LLC | 5,618,779 | $36,353,500 | 1.23% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $62,641,362 | 0.97% |